Author:
Demir Ramiz,Koc Soner,Ozturk Deniz Gulfem,Bilir Sukriye,Ozata Halil İbrahim,Williams Rhodri,Christy John,Akkoc Yunus,Tinay İlker,Gunduz-Demir Cigdem,Gozuacik Devrim
Abstract
AbstractBladder cancer is one of the most common cancer types in the urinary system. Yet, current bladder cancer diagnosis and follow-up techniques are time-consuming, expensive, and invasive. In the clinical practice, the gold standard for diagnosis remains invasive biopsy followed by histopathological analysis. In recent years, costly diagnostic tests involving the use of bladder cancer biomarkers have been developed, however these tests have high false-positive and false-negative rates limiting their reliability. Hence, there is an urgent need for the development of cost-effective, and non-invasive novel diagnosis methods. To address this gap, here we propose a quick, cheap, and reliable diagnostic method. Our approach relies on an artificial intelligence (AI) model to analyze droplet patterns of blood and urine samples obtained from patients and comparing them to cancer-free control subjects. The AI-assisted model in this study uses a deep neural network, a ResNet network, pre-trained on ImageNet datasets. Recognition and classification of complex patterns formed by dried urine or blood droplets under different conditions resulted in cancer diagnosis with a high specificity and sensitivity. Our approach can be systematically applied across droplets, enabling comparisons to reveal shared spatial behaviors and underlying morphological patterns. Our results support the fact that AI-based models have a great potential for non-invasive and accurate diagnosis of malignancies, including bladder cancer.
Funder
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249. https://doi.org/10.3322/caac.21660 (2021).
2. Antoni, S. et al. Bladder cancer incidence and mortality: A global overview and recent trends. Eur. Urol. 71, 96–108. https://doi.org/10.1016/j.eururo.2016.06.010 (2017).
3. Silverman, D. T., Koutros, S., Figueroa, J. D., Prokunina-Olsson, L. & Rothman, N. in Cancer Epidemiology and Prevention (ed Michael Thun) 977–996 (Oxford Academic, 2017).
4. Teoh, J. Y. et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur. Urol. 78, 893–906. https://doi.org/10.1016/j.eururo.2020.09.006 (2020).
5. Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E. & Theodorescu, D. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer 21, 104–121. https://doi.org/10.1038/s41568-020-00313-1 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献